What Are the Advantages and Disadvantages of Human Embryonic Kidney (HEK) Cells for the Analysis of Uptake Transporters?
![Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/037/269/small/pharmaceuticals-biotechnology-pharma-biotech-resources.jpg)
Summary: Dr. Jörg König from the Institute for Experimental and Clinical Pharmacology and Clinical Toxicology at Friedrich-Alexander-University Erlangen-Nürnberg, Germany , speaks to Rebecca Maschke from Pharma IQ, about the analysis of transporter-mediated drug-drug interactions,